PUBLISHER: Grand View Research | PRODUCT CODE: 1751548
PUBLISHER: Grand View Research | PRODUCT CODE: 1751548
The global vascular access procedures market size was estimated at USD 90.7 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2030. Vascular access procedures are used to enter the bloodstream for treatments like medication, fluids, or dialysis. The increasing incidence of chronic diseases is one of the major factors boosting market growth.
According to the Department of Biotechnology article published in February 2025, chronic diseases account for around 73% of deaths globally every year, reflecting a significant shift in the global health landscape toward long-term, non-communicable conditions. This growing burden has intensified the demand for consistent and reliable medical interventions that support ongoing treatment. Vascular access procedures have become critical in managing these conditions, enabling the safe and repeated administration of chemotherapy, hemodialysis, and intravenous medications. The healthcare systems increasingly focus on managing chronic illnesses over extended periods, and the importance of efficient vascular access solutions continues to grow, driving market growth.
Increased cancer cases drive the market growth. According to the WHO article published in February 2024, Cancer remains a leading global health burden, with an estimated 1 in 5 people likely to develop the disease during their lifetime. Mortality rates are also significant, with about 1 in 9 men and 1 in 12 women expected to die from cancer-related causes. Projections indicate a steep rise in new cases, reaching approximately 35 million by 2050, up nearly 77% from the estimated 20 million in 2022. This sharp increase underscores the urgent need for efficient treatment delivery, particularly vascular access procedures, critical for administering chemotherapy and other intravenous therapies. The cancer incidence continues to grow, especially among aging populations, and in low- to middle-income countries, the demand for dependable vascular access will be crucial to ensuring timely and continuous care, thereby driving strong market growth.
Increasing use of vascular access devices for pediatric patients drives the market's growth. According to an NCBI article published in October 2024, a long-term study spanning 4.5 years in two university-affiliated Pediatric Intensive Care Units (PICUs) examined 220 pediatric patients. It revealed significant dependence on vascular access devices, with a total of 683 devices utilized. Half of the patients required three or more devices during their treatment, and over half (54%) experienced at least one complication related to vascular access. This high usage rate and associated complication frequency reflect the critical role of vascular access procedures in managing seriously ill pediatric populations. The data highlights a growing demand for advanced, safer, and more efficient vascular access solutions, further driving the market growth.
Technological advancements in vascular access procedures drive the market growth. According to the Cornell University article published in October 2024, the Micro Smart Tissue Autonomous Robot (micro-STAR), a technologically advanced surgical robot that autonomously performs vascular anastomosis, particularly on small-diameter blood vessels. This device is equipped with Optical Coherence Tomography (OCT) and a microcamera, allowing it to navigate and complete sutures safely. In ex vivo studies, micro-STAR demonstrated outcomes on par with those of experienced surgeons, completing 90% of sutures without human intervention. This advancement is particularly valuable in surgeries requiring the reconnection of small vessels, such as in coronary artery bypass grafting (CABG) and dialysis access surgery for patients with end-stage renal disease.
Moreover, in April 2025, another promising development is integrating a 6-degrees-of-freedom (DoF) robotic arm combined with a 3-DoF end-effector, which utilizes ultrasound guidance to perform precise needle insertion into small-diameter veins and arteries. In in vivo studies on rats, this robotic system achieved a 95% first-attempt success rate, showcasing its ability to navigate difficult vascular access points, particularly in pediatric and geriatric patients who often have more fragile and challenging venous anatomy. This system holds potential for treating conditions like vascular malformations, deep vein thrombosis, and chemotherapy-related venous access, where accurate and minimally invasive access is critical. Thus, these advancements drive the market growth.
Global Vascular Access Procedures Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and analyzes the industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global vascular access procedures market report based on procedure type, application, and region: